Hanen Ghozzi
Research Subjects
Hanen Ghozzi has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Lobna Ben Mahmoud
Research Laboratory: LR19ES10 “Acute Medicine, Pharmacology, and Toxicology of Xenobiotics,” Faculty of Medicine of Sfax, University of Sfax
16 shared publications Ahmed Hakim
Centre régional de pharmacovigilance de Sfax, 3029 Sfax, Tunisie
15 shared publicationsKhaled Zeghal
Centre régional de pharmacovigilance de Sfax, 3029 Sfax, Tunisie
11 shared publicationsZouheir Sahnoun
Department of Pharmacology Faculty of Medicine University of Sfax Sfax Tunisia
8 shared publicationsA. Hakim
Service de pneumo-allergologie, CHU Hédi-Chaker de Sfax, université de Sfax, Tunisie
5 shared publicationsK. Zeghal
Laboratoire de pharmacologie, faculté de médecine de Sfax, université de Sfax, Tunisie
5 shared publications
Latest Publications
- 1 February 2020
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 60 (1) , 15-19
Intérêt d’une consultation d’allergologie au décours d’une réaction d’hypersensibilité immédiate aux anesthésiques généraux
- 1 February 2020
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 60 (1) , 15-19
Intérêt d’une consultation d’allergologie au décours d’une réaction d’hypersensibilité immédiate aux anesthésiques généraux
- Open Access
- 16 October 2019
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (2) , e23050
Relationship of oxidative stress in the resistance to imatinib in Tunisian patients with chronic myeloid leukemia: A retrospective study
Background: This work aimed to evaluate oxidative stress in chronic myeloid leukemia (CML) patients treated with tunisian (IM) vs controls and in CML patients with resistance to IM vs patients without resistance to IM. Methods: The study included 40 CML patients and 34 controls. Of 40 patients with CML, 26 patients were developed in resistance to IM. The oxidant/antioxidant markers were evaluated by spectrophotometric methods for all used samples. Results: For CML patients, increased malondialdehyde (MDA) and advanced oxidation protein products (AOPP) levels were found compared to controls ( P < .001; P = .01). Higher catalase (CAT) activity ( P = .048) and lower superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, reduced Glutathione (GSH) and vitamin C levels were found in CML patients ( P < .001). The comparison between the resistant vs no‐resistant CML patients revealed higher MDA level ( P = .02) and CAT and SOD activities in IM‐resistant patients ( P = .04, P = .03). GPx activity was reduced ( P = .04). Furthermore, increased mean ratio of MDA/GSH, MDA/GPx, and SOD/(GPx + CAT) was found in IM‐resistant patients as compared with no‐resistant ( P = .01, P = .01, P = .035). The mean ratio of GPx/GSH in the IM‐resistant CML patients was lower than in IM no‐resistant one ( P = .039). For IM‐resistant patients, we found negative correlation between MDA level and the ratio SOD/(CAT + GPx) ( r = −0.46, P = .002); and positive correlation between SOD and (CAT + GPx) activities ( r = 0.38, P = .06) and between GSH level and GPx activity ( r = 0.53, P = .01). Conclusions: Our results have shown a highly disturbed oxidative profile in IM‐resistant CML patients as compared to no‐resistant. The H 2 O 2 has a key role in the resistance to IM treatment.
- 16 October 2019
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (2) , e23050
Open AccessRelationship of oxidative stress in the resistance to imatinib in Tunisian patients with chronic myeloid leukemia: A retrospective study
Background: This work aimed to evaluate oxidative stress in chronic myeloid leukemia (CML) patients treated with tunisian (IM) vs controls and in CML patients with resistance to IM vs patients without resistance to IM. Methods: The study included 40 CML patients and 34 controls. Of 40 patients with CML, 26 patients were developed in resistance to IM. The oxidant/antioxidant markers were evaluated by spectrophotometric methods for all used samples. Results: For CML patients, increased malondialdehyde (MDA) and advanced oxidation protein products (AOPP) levels were found compared to controls ( P < .001; P = .01). Higher catalase (CAT) activity ( P = .048) and lower superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, reduced Glutathione (GSH) and vitamin C levels were found in CML patients ( P < .001). The comparison between the resistant vs no‐resistant CML patients revealed higher MDA level ( P = .02) and CAT and SOD activities in IM‐resistant patients ( P = .04, P = .03). GPx activity was reduced ( P = .04). Furthermore, increased mean ratio of MDA/GSH, MDA/GPx, and SOD/(GPx + CAT) was found in IM‐resistant patients as compared with no‐resistant ( P = .01, P = .01, P = .035). The mean ratio of GPx/GSH in the IM‐resistant CML patients was lower than in IM no‐resistant one ( P = .039). For IM‐resistant patients, we found negative correlation between MDA level and the ratio SOD/(CAT + GPx) ( r = −0.46, P = .002); and positive correlation between SOD and (CAT + GPx) activities ( r = 0.38, P = .06) and between GSH level and GPx activity ( r = 0.53, P = .01). Conclusions: Our results have shown a highly disturbed oxidative profile in IM‐resistant CML patients as compared to no‐resistant. The H 2 O 2 has a key role in the resistance to IM treatment.
- Open Access
- 31 August 2018
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 27 (8) , 1061-1068
Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia
Methotrexate (MTX) is a key component of acute lymphoblastic leukemia (ALL) therapy, but it is associated with serious toxicities in a considerable number of patients. The aim of the current study was to determine which variables were associated with MTX toxicity in children, adolescents and young adults with ALL. In this prospective study, 35 patients with newly diagnosed ALL, treated according to the 58951 European Organization for Research and Treatment of Cancer - Children's Leukemia Group (EORTC-CLG) protocol, were prospectively enrolled. Toxicity data was collected objectively after each high-dose methotrexate (HD-MTX) course. The risk factors of MTX toxicity were determined using multiple linear regression analysis, with age, gender, immunophenotype, risk group, plasma MTX levels, plasma homocysteine (HCY) levels, and MTHFR C677T included as independent variables. Twenty-five (71.4%) patients experienced toxicity on at least 1 course of HD-MTX. In the univariate linear regression, the global toxicity score was associated with a significant rise in plasma HCY concentrations within 48 h after MTX administration (β = 0.4; R2 = 0.12; p = 0.02). In the multiple regression model, the global toxicity score was significantly associated with a higher MTX plasma levels at 48 h (β = 0.5; R2 = 0.38; p = 0.001) and CT 677 MTHFR genotype (β = 0.3; R2 = 0.38; p = 0.01). Routine monitoring of plasma MTX concentrations is essential to detect patients at a high risk of MTX toxicity. MTHFR C677T genotyping may be useful for predicting MTX toxicity.
- 31 August 2018
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 27 (8) , 1061-1068
Open AccessUse of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia
Methotrexate (MTX) is a key component of acute lymphoblastic leukemia (ALL) therapy, but it is associated with serious toxicities in a considerable number of patients. The aim of the current study was to determine which variables were associated with MTX toxicity in children, adolescents and young adults with ALL. In this prospective study, 35 patients with newly diagnosed ALL, treated according to the 58951 European Organization for Research and Treatment of Cancer - Children's Leukemia Group (EORTC-CLG) protocol, were prospectively enrolled. Toxicity data was collected objectively after each high-dose methotrexate (HD-MTX) course. The risk factors of MTX toxicity were determined using multiple linear regression analysis, with age, gender, immunophenotype, risk group, plasma MTX levels, plasma homocysteine (HCY) levels, and MTHFR C677T included as independent variables. Twenty-five (71.4%) patients experienced toxicity on at least 1 course of HD-MTX. In the univariate linear regression, the global toxicity score was associated with a significant rise in plasma HCY concentrations within 48 h after MTX administration (β = 0.4; R2 = 0.12; p = 0.02). In the multiple regression model, the global toxicity score was significantly associated with a higher MTX plasma levels at 48 h (β = 0.5; R2 = 0.38; p = 0.001) and CT 677 MTHFR genotype (β = 0.3; R2 = 0.38; p = 0.01). Routine monitoring of plasma MTX concentrations is essential to detect patients at a high risk of MTX toxicity. MTHFR C677T genotyping may be useful for predicting MTX toxicity.
- 1 February 2018
- Vol. 31 (2) , 115-125
Potassium Bromate-induced Changes in the Adult Mouse Cerebellum Are Ameliorated by Vanillin
Objective The current study aimed to elucidate the effect of vanillin on behavioral changes, oxidative stress, and histopathological changes induced by potassium bromate (KBrO3), an environmental pollutant, in the cerebellum of adult mice. Methods The animals were divided into four groups: group 1 served as a control, group 2 received KBrO3, group 3 received KBrO3 and vanillin, and group 4 received only vanillin. We then measured behavioral changes, oxidative stress, and molecular and histological changes in the cerebellum. Results We observed significant behavioral changes in KBrO3-exposed mice. When investigating redox homeostasis in the cerebellum, we found that mice treated with KBrO3 had increased lipid peroxidation and protein oxidation in the cerebellum. These effects were accompanied by decreased Na+-K+ and Mg2+ ATPase activity and antioxidant enzyme gene expression when compared to the control group. Additionally, there was a significant increase in cytokine gene expression in KBrO3-treated mice. Microscopy revealed that KBrO3 intoxication resulted in numerous degenerative changes in the cerebellum that were substantially ameliorated by vanillin supplementation. Co-administration of vanillin blocked the biochemical and molecular anomalies induced by KBrO3. Conclusion Our results demonstrate that vanillin is a potential therapeutic agent for oxidative stress associated with neurodegenerative diseases.
- 1 February 2018
- Vol. 31 (2) , 115-125
Potassium Bromate-induced Changes in the Adult Mouse Cerebellum Are Ameliorated by Vanillin
Objective The current study aimed to elucidate the effect of vanillin on behavioral changes, oxidative stress, and histopathological changes induced by potassium bromate (KBrO3), an environmental pollutant, in the cerebellum of adult mice. Methods The animals were divided into four groups: group 1 served as a control, group 2 received KBrO3, group 3 received KBrO3 and vanillin, and group 4 received only vanillin. We then measured behavioral changes, oxidative stress, and molecular and histological changes in the cerebellum. Results We observed significant behavioral changes in KBrO3-exposed mice. When investigating redox homeostasis in the cerebellum, we found that mice treated with KBrO3 had increased lipid peroxidation and protein oxidation in the cerebellum. These effects were accompanied by decreased Na+-K+ and Mg2+ ATPase activity and antioxidant enzyme gene expression when compared to the control group. Additionally, there was a significant increase in cytokine gene expression in KBrO3-treated mice. Microscopy revealed that KBrO3 intoxication resulted in numerous degenerative changes in the cerebellum that were substantially ameliorated by vanillin supplementation. Co-administration of vanillin blocked the biochemical and molecular anomalies induced by KBrO3. Conclusion Our results demonstrate that vanillin is a potential therapeutic agent for oxidative stress associated with neurodegenerative diseases.
- 1 October 2017
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 88 (10) , 198-204
Optimization of therapeutic drug monitoring of vancomycin in patients with chronic hemodialysis
To validate a simplified vancomycin monitoring algorithm in patients on chronic hemodialysis who required intravenous vancomycin for at least 3 weeks. In this prospective study, all hemodialysis patients who were admitted between April 1, 2013, and March 31, 2015, in our unit for suspected or confirmed methicillin-resistant Staphylococcus aureus infection that required vancomycin were enrolled. All patients were categorized into two groups. In group 1 (standard vancomycin dosing algorithm), the maintenance doses of vancomycin were adjusted according to the pre-hemodialysis vancomycin concentrations determined before each hemodialysis session. In group 2 (simplified vancomycin dosing algorithm), pre-dialysis vancomycin trough levels were taken before the 2nd and the 6th session of hemodialysis. Maintenance doses were adjusted according to the residual concentrations of vancomycin. A total of 101 blood samples were collected, the average plasma concentration of vancomycin was 13.1 ± 3.8 µg/mL. 64 (63.4%) levels fell out of the therapeutic range. Seven (6.9%) of these exceeded the therapeutic range and 30 (29.7%) were lower. After the loading dose, the average plasma concentration was 11.2 ± 3.4 µg/mL. There were no statistically significant differences between the two groups with respect to the average plasma concentration of vancomycin and the proportion of vancomycin trough levels in the target range. The vancomycin dosing algorithm using limited concentration monitoring for hemodialysis patients achieved drug concentrations comparable to those found with more frequent monitoring and resulted in significant cost savings. .
- 1 October 2017
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 88 (10) , 198-204
Optimization of therapeutic drug monitoring of vancomycin in patients with chronic hemodialysis
To validate a simplified vancomycin monitoring algorithm in patients on chronic hemodialysis who required intravenous vancomycin for at least 3 weeks. In this prospective study, all hemodialysis patients who were admitted between April 1, 2013, and March 31, 2015, in our unit for suspected or confirmed methicillin-resistant Staphylococcus aureus infection that required vancomycin were enrolled. All patients were categorized into two groups. In group 1 (standard vancomycin dosing algorithm), the maintenance doses of vancomycin were adjusted according to the pre-hemodialysis vancomycin concentrations determined before each hemodialysis session. In group 2 (simplified vancomycin dosing algorithm), pre-dialysis vancomycin trough levels were taken before the 2nd and the 6th session of hemodialysis. Maintenance doses were adjusted according to the residual concentrations of vancomycin. A total of 101 blood samples were collected, the average plasma concentration of vancomycin was 13.1 ± 3.8 µg/mL. 64 (63.4%) levels fell out of the therapeutic range. Seven (6.9%) of these exceeded the therapeutic range and 30 (29.7%) were lower. After the loading dose, the average plasma concentration was 11.2 ± 3.4 µg/mL. There were no statistically significant differences between the two groups with respect to the average plasma concentration of vancomycin and the proportion of vancomycin trough levels in the target range. The vancomycin dosing algorithm using limited concentration monitoring for hemodialysis patients achieved drug concentrations comparable to those found with more frequent monitoring and resulted in significant cost savings. .
- 21 August 2017
- Published by Taylor & Francis in Biological Rhythm Research
- Vol. 49 (3) , 337-365
Monitoring athletes’ hydration status and sleep patterns during Ramadan observance: methodological and practical considerations
During Ramadan, dehydration and disturbed sleep patterns are common, so accurate reliable methods for the assessment of hydration and sleep of athletes are necessary to maintain performance. The purpose of this review is: (1) to identify appropriate tools/methods for monitoring hydration status and sleep in sports people; (2) to discuss which of these tools/methods can be confidently used by sport scientists and trainers during Ramadan; and (3) to discuss the possible link that may exist between sleep and hydration status. Several markers of hydration status are currently used and include body mass, plasma/serum osmolality, dilution techniques, and neutron activation analysis. Used in an appropriate context, all can be indicative of the hydration status in the laboratory. In the field, monitoring hydration status in physically active individuals and athletes may be performed using a combination of body mass with some measure of urine concentration (e.g. urine osmolality, urine-specific gravity, urine color) and sensation of thirst. During Ramadan, appropriate timing of sample collection and the use of reference methods in future studies are warranted. In the field, careful use of body mass in conjunction with urine indices may be used to monitor the hydration status of subjects practicing physical activity during Ramadan. There is a need for the use of polysomnography or actigraphy for sleep assessment during Ramadan in future laboratory-based studies of athletes. However, in the field, monitoring sleep–wake patterns may be performed using actigraphy and/or the PSQI questionnaire.
- 21 August 2017
- Published by Taylor & Francis in Biological Rhythm Research
- Vol. 49 (3) , 337-365
Monitoring athletes’ hydration status and sleep patterns during Ramadan observance: methodological and practical considerations
During Ramadan, dehydration and disturbed sleep patterns are common, so accurate reliable methods for the assessment of hydration and sleep of athletes are necessary to maintain performance. The purpose of this review is: (1) to identify appropriate tools/methods for monitoring hydration status and sleep in sports people; (2) to discuss which of these tools/methods can be confidently used by sport scientists and trainers during Ramadan; and (3) to discuss the possible link that may exist between sleep and hydration status. Several markers of hydration status are currently used and include body mass, plasma/serum osmolality, dilution techniques, and neutron activation analysis. Used in an appropriate context, all can be indicative of the hydration status in the laboratory. In the field, monitoring hydration status in physically active individuals and athletes may be performed using a combination of body mass with some measure of urine concentration (e.g. urine osmolality, urine-specific gravity, urine color) and sensation of thirst. During Ramadan, appropriate timing of sample collection and the use of reference methods in future studies are warranted. In the field, careful use of body mass in conjunction with urine indices may be used to monitor the hydration status of subjects practicing physical activity during Ramadan. There is a need for the use of polysomnography or actigraphy for sleep assessment during Ramadan in future laboratory-based studies of athletes. However, in the field, monitoring sleep–wake patterns may be performed using actigraphy and/or the PSQI questionnaire.
- 25 July 2017
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 28 (1) , 12-22
Modulatory effects of quercetin on liver histopathological, biochemical, hematological, oxidative stress and DNA alterations in rats exposed to graded doses of score 250
This study investigated the morphological, biochemical and molecular aspects of liver injury in rats after the exposure to difenoconazole and the protective effects of quercetin against hepatotoxicity and genotoxicity induced by this fungicide. Rats were given graded doses of difenoconazole associated or not to quercetin daily for 20 days. Our results showed a significant increase in PLT (platelets) and WBC (white blood cells) in rats treated with higher doses of difenoconazole (1/38 and 1/9 of LD50). However, a significant decrease in Hb (hemoglobin) rate and RBC (red blood cells) number in rats treated with higher doses of difenoconazole (1/38 and 1/9 of LD50) was obtained. Besides, difenoconazole treatment caused an increase in hepatic enzyme activities of alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH). Difenoconazole increased the levels of malondialdehyde (MDA) and advanced oxidation protein products (AOPPs), and decreased superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) activities and vitamin C levels in liver tissues compared to the control group. We also noted a degradation of nucleic acids, testifying difenoconazole genotoxicity. Changes in hepatic tissues were confirmed by histological findings. Co-administration of quercetin (20 mg/kg) improved hematological and biochemical parameters and showed a significant liver protective effect by decreasing MDA levels and producing advanced oxidation protein, along with increased antioxidative enzyme activities and vitamin C levels. Results were confirmed by the improvement of histological impairments. Thus, it appears that quercetin was effective in preventing acute liver injury induced by exposure to difenoconazole.
- 25 July 2017
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 28 (1) , 12-22
Modulatory effects of quercetin on liver histopathological, biochemical, hematological, oxidative stress and DNA alterations in rats exposed to graded doses of score 250
This study investigated the morphological, biochemical and molecular aspects of liver injury in rats after the exposure to difenoconazole and the protective effects of quercetin against hepatotoxicity and genotoxicity induced by this fungicide. Rats were given graded doses of difenoconazole associated or not to quercetin daily for 20 days. Our results showed a significant increase in PLT (platelets) and WBC (white blood cells) in rats treated with higher doses of difenoconazole (1/38 and 1/9 of LD50). However, a significant decrease in Hb (hemoglobin) rate and RBC (red blood cells) number in rats treated with higher doses of difenoconazole (1/38 and 1/9 of LD50) was obtained. Besides, difenoconazole treatment caused an increase in hepatic enzyme activities of alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH). Difenoconazole increased the levels of malondialdehyde (MDA) and advanced oxidation protein products (AOPPs), and decreased superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) activities and vitamin C levels in liver tissues compared to the control group. We also noted a degradation of nucleic acids, testifying difenoconazole genotoxicity. Changes in hepatic tissues were confirmed by histological findings. Co-administration of quercetin (20 mg/kg) improved hematological and biochemical parameters and showed a significant liver protective effect by decreasing MDA levels and producing advanced oxidation protein, along with increased antioxidative enzyme activities and vitamin C levels. Results were confirmed by the improvement of histological impairments. Thus, it appears that quercetin was effective in preventing acute liver injury induced by exposure to difenoconazole.